Q-Line Biotech Limited

## OUR SUBSIDIARY COMPANY

As on the date of this Draft Red Herring Prospectus, our Company has one Subsidiary Company being Q-Line Innovations Private Limited. Set out below are details of our Subsidiary Company:

### 1. Q-Line Innovations Private Limited ("QLIPL")

#### a. Corporate Information

The Company was incorporated as Q-Line Innovations Private Limited under the provisions of the Companies Act, 2013 with the Registrar of Companies, Central Registration Centre.

<table><tr><td>CIN</td><td>U73100UP2022PTC175239</td></tr><tr><td>Date of Incorporation</td><td>December 19, 2022</td></tr><tr><td>PAN</td><td>AAACQ8746Q</td></tr><tr><td>Registered Office</td><td>298- 281, Transport Nagar, Kanpur Road, Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh, India, 226023</td></tr></table>

#### b. Nature of Business

QLIPL is authorized to carry on the research and developmental activities to develop new surgical, medical, dental, diagnostic and scientific equipment, accessories, kits, re-agents & consumables, etc. and substitute for imported products and to develop and maintain testing house and laboratory for own use and for others and to carry on the business of manufacturing, buying, selling, importing, exporting, packaging, labelling, lease, renting of and generally dealing in all types of above mentioned products, etc.

#### c. Capital Structure

The following table sets forth details of the capital structure of QLIPL:

<table><thead><tr><th>Particulars</th><th>Aggregate value at face value (In ₹)</th></tr></thead><tbody><tr><td><strong>Authorized Capital</strong></td><td></td></tr><tr><td>1,50,000 Equity Shares of ₹10 each</td><td>15,00,000</td></tr><tr><td><strong>Issued, subscribed and paid-up capital</strong></td><td></td></tr><tr><td>10,000 Equity Shares of ₹10 each</td><td>1,00,000</td></tr></tbody></table>

#### d. Shareholding Pattern

The following table sets forth details of the shareholding pattern of QLIPL as on the date of Draft Red Herring Prospectus:

##### Equity Shares

<table><thead><tr><th>S. No.</th><th>Name of the Shareholder</th><th>No. of equity Shares of ₹ 10 each</th><th>% of total equity shareholding</th></tr></thead><tbody><tr><td>1.</td><td>Saurabh Garg</td><td>1,800</td><td>18.00%</td></tr><tr><td>2.</td><td>Amita Garg</td><td>1,200</td><td>12.00%</td></tr><tr><td>3.</td><td>Q-Line Biotech Limited</td><td>7,000</td><td>70.00%</td></tr><tr><td></td><td><strong>TOTAL</strong></td><td><strong>10,000</strong></td><td><strong>100.00%</strong></td></tr></tbody></table>

#### e. Board of Directors

Following are the Directors of QLIPL as on the date of this Draft Red Herring Prospectus:

<table><thead><tr><th>Name of Director</th><th>DIN</th><th>Designation</th></tr></thead><tbody><tr><td>Saurabh Garg</td><td>02891621</td><td>Director</td></tr><tr><td>Amita Garg</td><td>02891610</td><td>Director</td></tr><tr><td>Ayush Garg</td><td>08748016</td><td>Director</td></tr><tr><td>Amit Saraswat</td><td>10096723</td><td>Director</td></tr></tbody></table>

#### f. Financial Performance

The brief financial details of QLIPL derived from its audited financial statements for Fiscal 2024-25, 2023-24, 2022-23 is set

318